From: Advanced glycation endproducts and their receptor in different body compartments in COPD
 | Young healthy | Old healthy | COPD |
---|---|---|---|
 | n = 108 | n = 83 | n = 97 |
Age, years | 25 (66) | 54 (8.9) | 62 (7.6) |
Males, n (%) | 54 (50) | 60 (72) | 68 (70) |
Current smokers, n (%) | 72 (67) | 54 (65) | 51 (53) |
Cigarettes per day | 9 (6.8) | 16 (7.1) | 11 (7.9) |
Packyears | 3.1 (4.8) | 20 (18.0) | 38 (16.8) |
BMI, kg/m2 | 23.0 (2.8) | 25.3 (3.6) | 25.5 (4.7) |
FEV1, %pred | 108 (9.5) | 110 (13.5) | 62 (27) |
FEV1/FVC, % | 85 (5.7) | 79 (5.0) | 48 (14) |
RV/TLC, % | 23.3 (5.1) | 31.1 (4.4) | 45.8 (11.3) |
FEF25-75, %pred | 101 (18.7) | 100 (30.4) | 24 (17) |
DLCOc/VA, %pred | 97 (13.3) | 98 (12.6) | 67 (24) |
DLCO %pred | 91.6 (12.0) | 90.0 (12.3) | 61.6 (23.6) |
LDL cholesterol, mmol/L | 2.6 (0.8) | 3.6 (1.0 | 3.4 (1.0) |
Triglycerides, mmol/L | 1.0 (0.8) | 1.4 (1.0) | 1.2 (0.7) |
Fasting glucose, mmol/L | 5.2 (1.3) | 5.6 (0.7) | 5.8 (0.7) |
Creatinine, μmol/L | 73.7 (10.9) | 80.2 (14.5) | 82.7 (14.8) |